S. Meadows–Shropshire

21 total papers · 2.8k total citations
16 papers, 758 citations indexed

About

S. Meadows–Shropshire is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, S. Meadows–Shropshire has authored 16 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in S. Meadows–Shropshire's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (4 papers) and Systemic Lupus Erythematosus Research (3 papers). S. Meadows–Shropshire is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (4 papers) and Systemic Lupus Erythematosus Research (3 papers). S. Meadows–Shropshire collaborates with scholars based in United States, Spain and China. S. Meadows–Shropshire's co-authors include Rubén Burgos‐Vargas, Kathy Nicholls, Richard Furie, Frédéric Houssiau, Joan T. Merrill, Jan Hillson, Shun‐le Chen, Tien‐Tsai Cheng, Emiliano Calvo and Filippo de Braud and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

S. Meadows–Shropshire

15 papers receiving 752 citations

Hit Papers

normalize citations (0→100%) normalize lifespan (0→100%) sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

2023 64 citations Tina Cascone, Mark M. Awad et al. Annals of Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
S. Meadows–Shropshire	362	221	220	210	208	16	758
Jean Tayar	451 1.2×	163 0.7×	138 0.6×	230 1.1×	57 0.3×	30	842
Shazad Q. Ashraf	400 1.1×	141 0.6×	114 0.5×	22 0.1×	357 1.7×	22	834
Beatrice Coupes	140 0.4×	186 0.8×	93 0.4×	68 0.3×	99 0.5×	27	711
Charles E. Alpers	82 0.2×	161 0.7×	113 0.5×	189 0.9×	85 0.4×	16	811
Markus Zeisbrich	77 0.2×	286 1.3×	168 0.8×	133 0.6×	59 0.3×	16	648
Vera Genitsch	152 0.4×	147 0.7×	197 0.9×	59 0.3×	319 1.5×	23	647
Michelle Rashford	226 0.6×	119 0.5×	60 0.3×	30 0.1×	142 0.7×	10	638
Matt Truman	269 0.7×	51 0.2×	393 1.8×	78 0.4×	36 0.2×	25	632
Flora Sotsiou	130 0.4×	97 0.4×	167 0.8×	276 1.3×	95 0.5×	26	762
Dan Birmingham	79 0.2×	381 1.7×	57 0.3×	373 1.8×	41 0.2×	20	730

Countries citing papers authored by S. Meadows–Shropshire

Since Specialization

Citations

This map shows the geographic impact of S. Meadows–Shropshire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Meadows–Shropshire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Meadows–Shropshire more than expected).

Fields of papers citing papers by S. Meadows–Shropshire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Meadows–Shropshire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Meadows–Shropshire. The network helps show where S. Meadows–Shropshire may publish in the future.

Co-authorship network of co-authors of S. Meadows–Shropshire

This figure shows the co-authorship network connecting the top 25 collaborators of S. Meadows–Shropshire. A scholar is included among the top collaborators of S. Meadows–Shropshire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Meadows–Shropshire. S. Meadows–Shropshire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact